DOACs only and warfarin only are more likely to be prescribed to Medicare beneficiaries seeing clinicians in rural areas compared with urban areas.

Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) anticoagulant, today highlighted a key opinion leader presen ...

Uttarakhand government endorses medicinal leech therapy as a non-invasive treatment for post-surgical recovery and skin rejuvenation, amidst growing interest and some controversy.

Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) (the "Company" or "Cadrenal"), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to provide safer and ...

No matter whether patients had CAD or not, the simpler regimen was linked to less mortality and major bleeding at 6 months.

Sandra Lesenfants, senior vice president of Abbott’s Structural Heart business, shares an update on MitraClip, TriClip, and ...

Pfizer reported earnings that topped expectations Tuesday following an uptick in sales of a Covid-19 therapeutic and gains from other products.

New evidence supports the use of direct oral anticoagulants in the treatment of cerebral venous thrombosis. Abu Dhabi, UAE — New evidence supports the use of direct oral anticoagulants in the ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Much of the research in optimizing anticoagulant therapy for acute VTE has been carried out in patients without malignancies. Given the aggressive natural history of VTE in cancer patients ...

Another anticoagulant available for thromboprophylaxis is fondaparinux, an indirect inhibitor of activated factor X. In a double-blind, non-inferiority trial of 2,927 patients undergoing high-risk ...

Participants were survivors of acute ischemic strokes likely related to their Afib. In the hospital stroke unit, they were ...